Clinical Trial Update: NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study [NA]

View source ↗

Summary

Post-approval study update for NeoMend ProGEL Pleural Air Leak Sealant; completed trial with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lung Tumor

Drugs mentioned

• NeoMend ProGEL (ProGEL pleural air leak sealant)

Snippet

Sponsor: C. R. Bard | Conditions: Lung Cancer, Lung Tumor | NA | Status: COMPLETED | Results posted: 2017-07-11